Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Judges Scientific ( (GB:JDG) ) has provided an update.
Judges Scientific plc reported that Chief Financial Officer Brad Ormsby and his spouse executed a “Bed and ISA” transaction involving 753 ordinary shares on 2 April, selling the shares at 4,300p apiece and immediately repurchasing an equivalent amount into their individual ISAs at 4,305p per share. The move, a routine tax-efficient re-registration rather than a disposal, leaves Ormsby’s beneficial interest unchanged at 4,666 shares, or about 0.07% of the company, signalling no shift in executive exposure to the stock while underscoring ongoing insider participation.
The transaction was conducted on the London Stock Exchange’s AIM market and formally notified as required for persons discharging managerial responsibilities and their closely associated persons. With Ormsby’s stake maintained and no new capital raised or withdrawn, the disclosure primarily provides transparency to investors on insider dealings rather than indicating any change to Judges Scientific’s capital structure or strategic direction.
The most recent analyst rating on (GB:JDG) stock is a Sell with a £4015.00 price target. To see the full list of analyst forecasts on Judges Scientific stock, see the GB:JDG Stock Forecast page.
Spark’s Take on JDG Stock
According to Spark, TipRanks’ AI Analyst, JDG is a Neutral.
Judges Scientific’s strong financial performance and positive corporate events are significant strengths, contributing to a solid overall score. However, the stock’s technical indicators suggest caution, and its high P/E ratio indicates potential overvaluation. The absence of recent earnings call data limits insights into current management sentiment and guidance.
To see Spark’s full report on JDG stock, click here.
More about Judges Scientific
Judges Scientific plc, listed on AIM, is a U.K.-based consolidator in the scientific instruments sector, comprising 25 acquired businesses since 2005. Its portfolio companies sell specialized instrumentation globally to universities, research institutions, manufacturers, and regulators, focusing on niche markets with resilient margins and long-term growth potential. The group targets cash-generative businesses and aims to deliver shareholder returns through deleveraging, organic growth, and dividends.
Average Trading Volume: 27,485
Technical Sentiment Signal: Sell
Current Market Cap: £286.4M
Find detailed analytics on JDG stock on TipRanks’ Stock Analysis page.

